NCT00030602 2019-11-05
Vaccine Therapy in Treating Patients With Recurrent Prostate Cancer
University of Maryland, Baltimore
Phase 2 Completed
University of Maryland, Baltimore
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)